Patent details

Basic Information

Publication number:

EP3642338

PCT Application Number:

EP2018059677

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187176243

PCT Publication Number:

WO2018233895

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FUSION PROTEIN WITH HALF-LIFE EXTENDING POLYPEPTIDE

French Title of Invention:

PROTEINE FUSIONNEE COMPORTANT UN POLYPEPTIDE A DEMI-VIE PROLONGEE

German Title of Invention:

FUSIONSPROTEIN MIT POLYPEPTID DAS DIE HALBWERTSZEIT VERLÄNGERT

SPC Number:

Dates

Filing date:

16/04/2018

Grant date:

27/04/2022

EP Publication Date:

29/04/2020

PCT Publication Date:

27/12/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/04/2022

EP B1 Publication Date:

27/04/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/04/2023

Expiration date:

16/04/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/04/2022

 

 

Name:

Swedish Orphan Biovitrum AB (publ)

Address:

., 112 76 Stockholm, Sweden (SE)

Inventor

1

Name:

SVENSSON GELIUS, Stefan

Address:

Sweden (SE)

2

Name:

NORDLING, Erik

Address:

Sweden (SE)

3

Name:

NILSSON, Joakim

Address:

Sweden (SE)

Priority

Priority Number:

17176543

Priority Date:

19/06/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C12N 9/20;

Publication

European Patent Bulletin

Issue number:

202217

Publication date:

27/04/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages